Multinational enterprises and sustainable development. 1st ed

種類:

電子ブック

責任表示:

edited by Xiaolan Fu, Pervez N. Ghauri, Juha Väätänen

出版情報:

Bingley, UK : Emerald Publishing, 2017

著者名:

• Fu, Xiaolan
• Ghauri, Pervez N.
• Väätänen, Juha.

シリーズ名:

International business and management ; vol. 33

ISBN:

9781787431638 [1787431630]    

注記:

Includes bibliographical references.
Contents; List of Contributors ; About the Authors ; Introduction: How Multinational Enterprises Can Contribute to Achieving Sustainable Development Goals; 1. Sustainable Development Agenda: How Far We Have Gone?; 2. MNEmerge Project: Aims and Objectives; 3. Chapters in this Issue; References; The Impact of Multinational Enterprises on Sustainable Development and Poverty Reduction: Research Framework; 1. Introduction; 2. Research Question; 3. Theoretical Background; 4. Conceptual Framework; 5. Methodology.
5.1. Case Studies5.1.1. Case 1: Blue Skies, Ghana; 5.1.2. Case 2: Nestlé, Ghana; 5.1.3. Case 3: Novartis, India; 5.1.4. Case 4: Sanofi, India; 6. Findings; 6.2. Linkage and Spillover Effects; 6.3. Role of Policy Makers; 6.4. NGOs' Role; 6.5. Host Country Government Role; 6.6. Poverty Reduction; 7. Discussion and Conclusions; References; The Contribution of the Pharmaceutical Industry to the Health Status of the Developing World; 1. Introduction; 2. Setting the Background: Interrelationships between Health and Economic Development.
3. Pharmaceutical Products as Key Determinant of Health Outcomes3.1. Scoping Study on the Pharmaceutical Industry's Contribution to Health Promotion; 3.1.2. Results; 3.1.2.1. Areas of Contribution of Pharmaceutical Industry to Health in Developing Countries We classified the papers according to two broad categories of how pharmaceutical companies can contribute to health. We found that 36 articles focus on access to m.
3.1.2.4. Focus of Pharmaceutical MNEs Lastly, 54 out of the 76 articles retrieved in our search query specify at least one disease in the discussion on access to medicines and/or drug discoveries for the developing world. The absolute majority, as shown i4. Discussion and Conclusions; References; MNEs Contribution to the Indian Pharmaceutical Sector; 1. Introduction; 2. Research Questions; 3. Methods; 4. MNEs in the Indian Pharmaceutical Sector; 5. Foreign Direct Investment and MNEs in the Indian Pharmaceutical Sector; 6. Contribution of MNEs Toward Research and Development in India.
This volume reports the results of the large international 'MNEmerge' research project, financed by the European Commission, and provides an understanding of the impact of multinational enterprises on United Nations Millennium Development Goals and successive Sustainable Development Goals in developing countries.
Master record variable field(s) change: 072

ローカル注記:

学内専用E-BOOKS (local access only)